MRI features of demyelinating disease associated with anti-MOG antibodies in adults.
Journal of Neuroradiology. 2019-09-01; 46(5): 312-318
DOI: 10.1016/j.neurad.2019.06.001
Lire sur PubMed
Denève M(1), Biotti D(2), Patsoura S(3), Ferrier M(3), Meluchova Z(3), Mahieu L(4), Heran F(5), Vignal C(6), Deschamps R(7), Gout O(7), Champfleur NM(8), Ayrignac X(9), Dallière CC(9), Labauge P(9), Dulau C(10), Tourdias T(11), Dumas
H(3), Cognard C(3), Brassat D(2), Bonneville F(12).
Author information:
(1)Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France.
(2)Neurology department, Pierre-Paul Riquet/Purpan university hospital, 31300 Toulouse, France.
(3)Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France.
(4)Ophthalmology department, Pierre-Paul Riquet/Purpan university hospital, 31300 Toulouse, France.
(5)Radiology department, fondation A.-De Rothschild, 75019 Paris, France.
(6)Ophthalmology department, fondation A.-De Rothschild, 75019 Paris, France.
(7)Neurology department, fondation A.-De Rothschild, 75019 Paris, France.
(8)Neuroradiology department, CHU de Montpellier, 34295 Montpellier, France.
(9)Neurology department, CHU de Montpellier, 34295 Montpellier, France.
(10)Neurology department, CHU de Bordeaux, 33000 Bordeaux, France.
(11)Neuroradiology department, CHU de Bordeaux, 33000 Bordeaux, France.
(12)Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France.
The spectrum of Myelin Oligodendrocytes Glycoprotein (MOG) antibody disease constitutes a recently described challenging entity, referring to a relatively new spectrum of autoimmune disorders with antibodies against MOG predominantly involving the optic nerve and spinal cord. The purpose of this article is to describe MRI features of MOG-AD involvement in the optic nerves, spinal cord and the brain of adults.